Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of ADP101 in food allergic children and adults.

Clinical Trial Description

This is a multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of ADP101 for oral immunotherapy in food allergic children and adults. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04856865
Study type Interventional
Source Alladapt Immunotherapeutics, Inc.
Contact Alladapt Clinical Trial Team
Phone 650-420-3900
Email [email protected]
Status Recruiting
Phase Phase 1/Phase 2
Start date April 20, 2021
Completion date December 2022

See also
  Status Clinical Trial Phase
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Completed NCT02552537 - iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Phase 4
Completed NCT01634737 - Crustacean Allergy and Dust Mites Sensitization N/A
Recruiting NCT03265262 - The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy N/A
Active, not recruiting NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02490007 - Pertussis Immunisation and Food Allergy
Recruiting NCT03151252 - Improvement of Foodallergy Diagnostic in Gastrointestinal Tract N/A
Completed NCT02159833 - Intranasal Diagnostics in Food Allergy: a Feasibility Study N/A
Completed NCT02377284 - Prevention and Management of Food Allergies N/A
Completed NCT02354729 - Encouraging Allergic Young Adults to Carry Epinephrine N/A
Completed NCT02640560 - One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish N/A
Recruiting NCT04606615 - Skin Barrier Abnormalities and Oxidative Stress Response
Completed NCT02295397 - Integrated Approaches to Food Allergen and Allergy Risk Management N/A
Terminated NCT02341040 - Evaluation of Potential Allergenicity of New Wheat Varieties
Completed NCT02223182 - Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Phase 1/Phase 2
Completed NCT03349047 - Anxiety About Casual Exposure to Food Allergens N/A
Not yet recruiting NCT04761835 - STEP-IT-UP - Peanut Allergy Study for Infants Phase 2
Recruiting NCT04037176 - Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair) Phase 4
Completed NCT03463135 - A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients Phase 1
Active, not recruiting NCT03799328 - Low Dose Multi-OIT for Food Allergy (LoMo) Phase 2